Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$5.3 - $7.61 $381,170 - $547,303
71,919 Added 233.03%
102,782 $582,000
Q4 2023

Feb 14, 2024

BUY
$4.5 - $7.51 $36,990 - $61,732
8,220 Added 36.3%
30,863 $204,000
Q2 2023

Aug 14, 2023

BUY
$9.23 - $11.23 $208,994 - $254,280
22,643 New
22,643 $229,000
Q2 2021

Aug 16, 2021

SELL
$11.7 - $16.11 $211,746 - $291,558
-18,098 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.75 - $22.61 $140,259 - $409,195
18,098 New
18,098 $235,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $53.4M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.